18F-fallypride

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug Name18F-fallypride
Drug Alias Name18F-fallypride
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSubstance Withdrawal SyndromeOpioid-Related DisordersDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California In Digital Irvine
China Registration ClassN/A

Develop Information

Active CompaniesEmory University
Inactive CompaniesUniversity Of California In Digital Irvine
Active IndicationsSubstance Withdrawal SyndromeOpioid-Related Disorders
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A